Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
A phase 3 trial of Nivolumab, Epacadostat, Carboplatin, Cisplatin, Gemcitabine, Paclitaxel / nab-paclitaxel and Pemetrexed in Lung cancer, run by Incyte Corporation, recorded as terminated on the registry.
Overview
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer is a phase 3 interventional study registered as NCT03348904 by Incyte Corporation, with 2 participants recorded, started 2017-12-27 and due to reach its primary completion in 2018-05-22. Interventions recorded: Nivolumab, Epacadostat, Placebo, Carboplatin, Cisplatin, Gemcitabine, Paclitaxel, Pemetrexed. Conditions recorded: Lung Cancer.
Linked to the drug Epacadostat because the registry names it among its interventions and Lung cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialPembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
Shares Epacadostat, Incyte, Cisplatin, Carboplatin and the tag pipeline.
- TrialCombination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
Shares Lung cancer (all types), Paclitaxel / nab-paclitaxel, Cisplatin, Carboplatin and the tag pipeline.
- TrialPembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Shares Epacadostat, Incyte and the tag pipeline.
- TrialA Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Shares Pemetrexed, Gemcitabine, Cisplatin, Carboplatin and the tag pipeline.
- TrialSystemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Shares Pemetrexed, Gemcitabine, Paclitaxel / nab-paclitaxel, Cisplatin and the tag pipeline.
- TrialStudy of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
Shares Gemcitabine, Nivolumab, Cisplatin, Carboplatin and the tag pipeline.
- TrialLDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer
Shares Pemetrexed, Cisplatin, Carboplatin and the tag pipeline.
- TrialPhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Shares Gemcitabine, Cisplatin, Carboplatin and the tag pipeline.